Back to Search
Start Over
Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics
- Source :
- British Journal of Cancer, British Journal of Cancer, 2014, 110 (10), pp.2615-2622. ⟨10.1038/bjc.2014.176⟩
- Publication Year :
- 2014
- Publisher :
- Nature Publishing Group, 2014.
-
Abstract
- International audience; Background: The revolution in cancer genomics shows that the dominant mutations are CG->TA transitions. The sources of these mutations are probably two host cell cytidine deaminases APOBEC3A and APOBEC3B. The former in particular can access nuclear DNA and monotonously introduce phenomenal numbers of C->T mutations in the signature 5'TpC context. These can be copied as G->A transitions in the 5'GpA context.Methods: DNA hypermutated by an APOBEC3 enzyme can be recovered by a technique called 3DPCR, which stands for differential DNA denaturation PCR. This method exploits the fact that APOBEC3-edited DNA is richer in A+T compared with the reference. We explore explicitly 3DPCR error using cloned DNA.Results: Here we show that the technique has a higher error rate compared with standard PCR and can generate DNA strands containing both C->T and G->A mutations in a 5'GpCpR context. Sequences with similar traits have been recovered from human tumour DNA using 3DPCR.Conclusions: Differential DNA denaturation PCR cannot be used to identify fixed C->T transitions in cancer genomes. Presently, the overall mutation frequency is ∼10(4)-10(5) base substitutions per cancer genome, or 0.003-0.03 kb(-1). By contrast, the 3DPCR error rate is of the order of 4-20 kb(-1) owing to constant selection for AT DNA and PCR-mediated recombination. Accordingly, sequences recovered by 3DPCR harbouring mixed C->T and G->A mutations associated with the 5'GpC represent artefacts.
- Subjects :
- MESH: Neoplasm Proteins
CD4-Positive T-Lymphocytes
Cancer Research
[SDV]Life Sciences [q-bio]
MESH: beta Catenin
Cytidine
medicine.disease_cause
Nucleic Acid Denaturation
Genome
Polymerase Chain Reaction
law.invention
Cytosine Deaminase
chemistry.chemical_compound
MESH: Liver Neoplasms
law
APOBEC Deaminases
APOBEC3A
MESH: Carcinoma, Hepatocellular
Polymerase chain reaction
Cells, Cultured
beta Catenin
Genetics
Recombination, Genetic
Mutation
Liver Neoplasms
MESH: APOBEC Deaminases
Temperature
MESH: CD4-Positive T-Lymphocytes
APOBEC3
DNA, Neoplasm
MESH: Temperature
MESH: Hepatitis C, Chronic
Nuclear DNA
Neoplasm Proteins
Oncology
MESH: Recombination, Genetic
MESH: Interferon-alpha
MESH: Cytidine
MESH: Cells, Cultured
MESH: Mutation
Carcinoma, Hepatocellular
MESH: Hepatitis B, Chronic
MESH: DNA, Neoplasm
Context (language use)
Genomics
MESH: Nucleic Acid Denaturation
Biology
MESH: Phytohemagglutinins
Hepatitis B, Chronic
Cytidine Deaminase
medicine
Humans
3DPCR
Phytohemagglutinins
MESH: Cytidine Deaminase
cancer genomics
MESH: Humans
MESH: Cytosine Deaminase
hypermutation
Interferon-alpha
MESH: Interleukin-2
MESH: Polymerase Chain Reaction
Genetics and Genomics
Hepatitis C, Chronic
chemistry
Interleukin-2
DNA
Subjects
Details
- Language :
- English
- ISSN :
- 15321827 and 00070920
- Volume :
- 110
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- British Journal of Cancer
- Accession number :
- edsair.doi.dedup.....bcfee682b49b4e289cb39e5876039f22
- Full Text :
- https://doi.org/10.1038/bjc.2014.176⟩